Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 08:41 am Sale | 13G | iTeos Therapeutics Inc. ITOS | RTW INVESTMENTS LP | 2,353,015 6.7% | -409,776 (-14.83%) | View |
2022-02-14 08:39 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | RTW INVESTMENTS LP | 2,980,960 6.6% | 2,980,960 (New Position) | View |
2022-02-14 08:22 am Purchase | 13G | Fulcrum Therapeutics Inc. FULC | RTW INVESTMENTS LP | 3,866,872 9.5% | 1,795,463 (+86.68%) | View |
2022-02-14 08:21 am Purchase | 13G | TELA BIO INC TELA | RTW INVESTMENTS LP | 1,399,686 9.7% | 15,870 (+1.15%) | View |
2022-02-14 08:20 am Unchanged | 13G | ESTABLISHMENT LABS HOLDINGS INC. ESTA | RTW INVESTMENTS LP | 2,319,138 9.7% | 0 (Unchanged) | View |
2022-02-14 08:18 am Sale | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,013,601 9.7% | -450,000 (-18.27%) | View |
2022-02-14 08:16 am Purchase | 13G | BRAINSWAY LTD SPONSORED ADS BWAY | RTW INVESTMENTS LP | 3,204,762 9.7% | 997,814 (+45.21%) | View |
2022-02-14 08:12 am Purchase | 13G | IMMUNIC INC IMUX | RTW INVESTMENTS LP | 1,715,470 6.5% | 1,715,470 (New Position) | View |
2022-02-14 08:12 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC AVDL | RTW INVESTMENTS LP | 5,810,140 9.99% | 422,627 (+7.84%) | View |
2022-02-14 08:10 am Purchase | 13G | PROQR THERAPEUTICS N.V. PRQR | RTW INVESTMENTS LP | 7,027,725 9.9% | 1,939,232 (+38.11%) | View |
2022-02-14 08:09 am Sale | 13G | Athira Pharma Inc. ATHA | RTW INVESTMENTS LP | 1,906,557 5.1% | -779,222 (-29.01%) | View |
2022-02-14 08:09 am Purchase | 13G | Apyx Medical Corp APYX | RTW INVESTMENTS LP | 3,398,279 9.9% | 7,000 (+0.21%) | View |
2022-02-14 08:07 am Purchase | 13G | Stoke Therapeutics Inc. STOK | RTW INVESTMENTS LP | 3,644,248 9.9% | 100,000 (+2.82%) | View |
2022-02-14 08:07 am Sale | 13G | Protagonist Therapeutics Inc PTGX | RTW INVESTMENTS LP | 2,599,822 5.4% | -1,050,247 (-28.77%) | View |
2022-02-14 08:05 am Purchase | 13G | Renovacor Inc. RCOR | RTW INVESTMENTS LP | 2,997,540 17% | 2,997,540 (New Position) | View |
2022-02-14 08:03 am Purchase | 13G | BELLUS Health Inc. BLU | RTW INVESTMENTS LP | 5,968,017 5.8% | 778,155 (+14.99%) | View |
2022-02-14 08:03 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW INVESTMENTS LP | 4,315,102 14.4% | -99 (-0.00%) | View |
2022-02-14 08:00 am Purchase | 13G | PTC THERAPEUTICS INC. PTCT | RTW INVESTMENTS LP | 5,293,966 7.5% | 325,757 (+6.56%) | View |
2021-12-15 2:28 pm Purchase | 13G | ADICET BIO INC ACET | RTW INVESTMENTS LP | 3,023,744 7.91% | 3,023,744 (New Position) | View |
2021-12-08 2:06 pm Purchase | 13G | CytomX Therapeutics Inc. CTMX | RTW INVESTMENTS LP | 5,868,326 8.99% | 5,868,326 (New Position) | View |